コンテンツへスキップ
Merck
  • Mutation in mitochondrial ribosomal protein S7 (MRPS7) causes congenital sensorineural deafness, progressive hepatic and renal failure and lactic acidemia.

Mutation in mitochondrial ribosomal protein S7 (MRPS7) causes congenital sensorineural deafness, progressive hepatic and renal failure and lactic acidemia.

Human molecular genetics (2015-01-04)
Minal J Menezes, Yiran Guo, Jianguo Zhang, Lisa G Riley, Sandra T Cooper, David R Thorburn, Jiankang Li, Daoyuan Dong, Zhijun Li, Joseph Glessner, Ryan L Davis, Carolyn M Sue, Stephen I Alexander, Susan Arbuckle, Paul Kirwan, Brendan J Keating, Xun Xu, Hakon Hakonarson, John Christodoulou
要旨

Functional defects of the mitochondrial translation machinery, as a result of mutations in nuclear-encoded genes, have been associated with combined oxidative phosphorylation (OXPHOS) deficiencies. We report siblings with congenital sensorineural deafness and lactic acidemia in association with combined respiratory chain (RC) deficiencies of complexes I, III and IV observed in fibroblasts and liver. One of the siblings had a more severe phenotype showing progressive hepatic and renal failure. Whole-exome sequencing revealed a homozygous mutation in the gene encoding mitochondrial ribosomal protein S7 (MRPS7), a c.550A>G transition that encodes a substitution of valine for a highly conserved methionine (p.Met184Val) in both affected siblings. MRPS7 is a 12S ribosomal RNA-binding subunit of the small mitochondrial ribosomal subunit, and is required for the assembly of the small ribosomal subunit. Pulse labeling of mitochondrial protein synthesis products revealed impaired mitochondrial protein synthesis in patient fibroblasts. Exogenous expression of wild-type MRPS7 in patient fibroblasts rescued complexes I and IV activities, demonstrating the deleterious effect of the mutation on RC function. Moreover, reduced 12S rRNA transcript levels observed in the patient's fibroblasts were also restored to normal levels by exogenous expression of wild-type MRPS7. Our data demonstrate the pathogenicity of the identified MRPS7 mutation as a novel cause of mitochondrial RC dysfunction, congenital sensorineural deafness and progressive hepatic and renal failure.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジメチルスルホキシド, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
ジメチルスルホキシド, ACS reagent, ≥99.9%
Sigma-Aldrich
ジメチルスルホキシド, for molecular biology
Sigma-Aldrich
ジメチルスルホキシド, suitable for HPLC, ≥99.7%
Sigma-Aldrich
ジメチルスルホキシド, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
ジメチルスルホキシド, ReagentPlus®, ≥99.5%
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
ジメチルスルホキシド, anhydrous, ≥99.9%
Sigma-Aldrich
ジメチルスルホキシド, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
ベタイン 溶液, 5 M, PCR Reagent
Sigma-Aldrich
トリシン, ≥99% (titration)
Sigma-Aldrich
ジメチルスルホキシド, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
ベタイン, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
ベタイン, ≥98% (perchloric acid titration)
Sigma-Aldrich
ジメチルスルホキシド, puriss. p.a., dried, ≤0.02% water
Sigma-Aldrich
ジメチルスルホキシド, PCR Reagent
Sigma-Aldrich
ジメチルスルホキシド, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
トリシン, BioPerformance Certified, suitable for cell culture, ≥99% (titration)
USP
ジメチルスルホキシド, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
トリシン, BioXtra, pH 4.0-6.0 (1 M in H2O), ≥99% (titration)
SAFC
トリシン
Sigma-Aldrich
ビシンコニン酸 二ナトリウム塩 水和物, ≥98% (HPLC)
Sigma-Aldrich
ジメチルスルホキシド 溶液, 50 wt. % in H2O
Supelco
ジメチルスルホキシド, analytical standard
Supelco
ジメチルスルホキシド, for inorganic trace analysis, ≥99.99995% (metals basis)
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5%
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Sigma-Aldrich
ジメチルスルホキシド, suitable for HPLC
Sigma-Aldrich
ジメチルスルホキシド, JIS special grade, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド, Vetec, reagent grade, 99%